Background: Postablation reentrant ATs depend upon conducting isthmuses bordered by scar.
INTRODUCTION
Electrophysiologists commonly use bipolar voltage maps to highlight areas of low voltage that might be considered as scar or electrically inert tissue. [1] [2] [3] It is frequently these areas that form the substrate for reentrant arrhythmias, and therefore they may be a target for ablation. 4 In cases of ventricular tachycardia, there is consensus that substrate modification is appropriate even after successful ablation of the presenting tachycardia. 5 However, in the atria it is unclear how to assess the arrhythmia substrate based upon electrogram recordings.
The mechanism of atrial tachycardia (AT) is often iatrogenic in origin-either due to previous atrial fibrillation (AF) ablation or cardiac surgery. [6] [7] [8] [9] Bipolar voltage maps during tachycardia may help to identify isthmuses of conducting tissue bordered by scar that support activation. [10] [11] [12] [13] [14] Whether the same scar distribution is seen with a change in activation vector or rate has not been studied in patients with AT following AF ablation. This is important, as if the isthmus locations remain concordant independent of the rhythm mapped, then this could guide substrate ablation outside of tachycardia for symptomatic patients noninducible on the day of their procedure or even at the time of their initial AF ablation procedure.
Such an empirical ablation approach requires an accurate method of defining scar and isthmuses. In relating bipolar voltage to scar in the ventricle, early work demonstrated that voltages <0.5 mV and >1.5 mV correlated well with histopathological specimens. 3, 15 However, the bipolar voltage amplitude may depend upon the myocardial activation sequence. Changes in amplitude can occur with variations in activation direction with respect to anisotropic tissue characteristics, or when variations in activation direction lead to wavefront collision. [16] [17] [18] Furthermore, unlike in the ventricle, a consensus for a bipolar voltage threshold that defines atrial scar does not exist.
We have described previously how Ripple Mapping (RM) can be used to determine electrically functional tissue, without a fixed bipolar voltage threshold, for the purposes of guiding activation mapping during AT in patients with previous AF ablation. 19, 20 RM is uniquely suited as it is the only mapping system that presents both voltage and activation simultaneously. [21] [22] [23] In this study, we retrospectively considered the hypothesis that the isthmuses of active tissue identified using RM are concordant and anatomically fixed between rhythms with different activation direction vector or atrial rate.
METHODS

Study population
The cases in this study were patients who underwent ablation for AT using RM, and in whom Ripple Maps for more than one atrial rhythm were collected over an approximate 12-month period in our institute.
The reasons for additional map collection were clinical: either to map a second tachycardia or to check for block of an ablation line. Only maps where electroanatomical data throughout all of the left atrium in both maps were considered. Consecutive patients were included, in whom these criteria were fulfilled. All participants gave informed consent and ethical approval was obtained from the National Research Ethics Service.
Procedures were performed under general anesthesia and with femoral vein access. Transesophageal echocardiography was used to exclude left atrial appendage (LAA) thrombus and to guide transseptal puncture. A decapolar catheter was placed into the coronary sinus (CS) for use as a reference. An electroanatomical mapping system was used (CARTO3v4, Biosense-Webster, Inc., Diamond Bar, CA, USA). A multielectrode mapping catheter (Lasso Nav or PentaRay Nav, BiosenseWebster, Inc.) was placed through sheaths into the left atrium (LA) and used for mapping the LA body and the pulmonary veins. Low voltage area < 0.3 mV was defined for each map as a percentage of the total LA surface area (excluding the pulmonary veins) using the CARTO surface area tool.
Data collection
The mapping catheter and method of data collection was identical for all maps acquired for each patient. The color threshold was set below 5 mm to ensure a dense and even spread of electrogram data across the map. To avoid the inclusion of erroneous or noncontact points on the map, several different functions of the map were selected. First, both internalized points >10 mm and nonrespiratory gated points were removed. Second, a series of filters that review each passing electrogram (EGM) picked up by the mapping catheters was activated (CARTO Confidense Continuous Mapping); this included a "cycle length (CL) range" filter that measured the CL between two beats and accepted those within 5% of the mapped CL, an "local activation time (LAT) stability" filter that compares the LAT of each new beat to the previous beat, and rejected those with LAT more than 3 ms, and a "position stability" filter that rejected points collected more than 2 mm away from a previous beat. Finally a "tissue proximity" filter was activated that uses impedance measurements to determine an electrode's proximity to the cardiac surface and rejects those points collected when greater than the radius of the electrode (assumed not to be in contact). 
Ripple map analysis
Active tissue thresholding and isthmus identification
During RM viewing, the atrial geometry was colored according to the interpolated bipolar voltage. At the start of the case, a voltage threshold of 0.3 mV was arbitrarily assigned (i.e., areas with Some isthmuses exist in all patients because of pulmonary venous isolation (PVI). These are at the roof, left mitral isthmus, and right mitral isthmus ( Figure 1 ). Isthmuses that were in these positions were subclassified as "expected," and otherwise "unexpected."
Ablation
Power controlled (25-35 W) radiofrequency (RF) energy was delivered (Stockert70 RF generator, Biosense-Webster, Inc.) through an irrigated ablation catheter (SmartTouch Thermocool) targeting the critical isthmus supporting the tachycardia circuit as part of the clinical procedure prior to remapping.
Statistical analysis
Categorical variables were expressed as percentages. Continuous variables were expressed as mean ± one standard deviation for parametric data and/or median (lower quartile-upper quartile) for nonparametric data. Paired data were analyzed using the Wilcoxon signed ranks and unpaired data were analyzed using a Mann-Whitney U test for nonparametric data. A two-sided P-value was determined where applicable and a value of P ≤ 0.05 was considered significant. SPSS Version 22 (IBM) was used for statistical analysis.
RESULTS
Ten patients (68 ± 7 years, 8 male) were studied with mapping of >1 left atrial activation pattern. All patients had undergone previous pulmonary vein isolation for AF. Previous ablation sometimes included a roof line (5/10 (50%)), mitral isthmus ablation (4/10 (40%)), and electrogram defragmentation (6/10 (60%)). There were 7 of 10 (70%) patients who had undergone two or more ablation procedures, including three patients who had been treated previously for an AT with ablation. Patient demographics are summarized in Table 1 .
A dense map of AT1 was collected in each patient (median 2,265 points (1,554-4,308). The median AT CL was 250 ms (238-300 ms). septum. The remaining 7 of 31 (23%) isthmuses were considered "unexpected," as they could not have been predicted based on the history of previous ablation. An example of an unexpected isthmus is shown in Figure 2 and Supplementary Video S1.
These maps were used during the clinical procedure and 11 of 31 (35%) isthmuses were ablated resulting in a change or termination of AT1 (2 anterior; 4 roof; 5 mitral). In one patient, owing to a dual loop roof and mitral-dependent tachycardia, both isthmuses required ablation prior to tachycardia termination. Table 2 .
There was no difference in point density between the maps for each Two isthmuses did not correspond well between Map 1 and Map 2. In both of these cases, RM revealed that there was wavefront collision at the isthmus site (1 anterior; 1 posterior). An example of this is presented in Figure 5 and in Supplementary Video S3. Abbreviations: CL = cycle length; ms = milliseconds; CS = coronary sinus; D-P = distal to proximal; P-D = proximal to distal; LAA = left atrial appendage. 
DISCUSSION
We have investigated the use of RM to define the isthmuses of active tissues supporting AT in the context of previous AF ablation. We assessed the reproducibility of these isthmuses in the presence of different atrial activation sequences. This study demonstrates general concordance in their distribution. Where there was not concordance then this was due to wavefront collision, and this can be identified using RM.
During ablation procedures, it can be difficult to differentiate scar from conducting tissue objectively. Predetermined voltage thresholds have not been useful in identifying atrial scar. 5 We have previously developed a simple method for Active Tissue Thresholding by using RM to personalize the bipolar voltage threshold for each patient. 19, 20 This current study was necessary to investigate its reproducibility: as each tachycardia is somewhat unique in its direction of activation and rate, repeat mapping of the same atrium might not necessarily create the same voltage. 16, 17, 24 This is the first study attempting to understand whether LA voltage maps are concordant in the same individual, when obtained in different rhythms (with different activation vectors or rate). The patients included had all undergone previous ablation for persistent AF and AT.
High-density mapping was used to characterize the substrate in detail (>2,000 points). Contact with the endocardial surface was reliable, determined using a tissue proximity filter based on impedance, and application of stringent point collection filters. Multipolar catheters with smaller tips and narrower interelectrode spacing were used for mapping to record accurate EGMs from smaller tissue diameter. 25 The concordance in isthmus locations observed in this study is important for those patients with paroxysmal arrhythmia planned for ablation and noninducible on the day of their procedure, precluding effective mapping. Ablation of all isthmuses within the atrial substrate mapped outside of tachycardia may be considered an alternative F I G U R E 5 Isthmus block secondary to change in activation direction and wavefront collision (see also Supplementary Video S3). RM demonstrated activation wavefronts above 0.15 mV. Both maps are displayed in AP. In AT1, two distinct wavefronts were seen travelling in a cranio-caudal direction from the roof, and caudo-cranial direction from the floor. The two wavefronts collided on the anterior wall, adjacent to the mitral annulus, and coalesced to form a single body of activation toward the RPVs. In AT2, both wavefronts are again present; however, the timing of the caudocranial wavefront is earlier resulting in wavefront collision in the mid anterior wall. Bipolar electrograms within the anterior wall measured >0.5 mV.
Electrograms from the site of collision in AT2 revealed very low voltage signals along the anterior wall, which were healthy in AT1, creating distinct voltage maps [Color figure can be viewed at wileyonlinelibrary.com] strategy for long-term abolition of atrial arrhythmia. 26 Feasibility of such an approach has been previously described. The bipolar voltage and LAT display of a single tachycardia was used to ablate all putative isthmuses thought related to otherwise unmappable ATs postsurgical atriotomy, achieving high rates of acute noninducibility and low recurrence at 1-year follow-up. 10 Atrial "scar" was identified by a bipolar voltage of ≤0.05-0.1 mV-this threshold originating from the baseline noise in early electroanatomic mapping systems, and points below this threshold were hidden behind gray "scar" tags when LAT mapping was used. 13 However, atrial-based substrate ablation approaches have yet to be routinely adopted, owing to absence of a universally accepted voltage threshold to define atrial scar. Furthermore, interpretation of LAT propagation in areas of low voltage can be misleading due to interpolation algorithms within unmapped sites (which assumes activation is uniform), and concern that incorrect assignment of LAT for a small number of low-amplitude fractionated EGMs can invalidate the entire activation map. Extensive ablation can prolong the intraatrial conduction time such that it exceeds the window of interest, and the timing of the true latest activation site displayed as early in the window with respect to the next cycle of activation. RM is not reliant upon annotation of activation time or setting a window of interest, as the bars are analyzed in relation to each other to establish the activation direction, and avoids interpolation within unmapped sites-an example of the benefit of RM over LAT interpretation is illustrated in Figure 2 . [19] [20] [21] In this study, we consider an approach to define atrial scar using RM. 19 dent." These tachycardias pass through isthmuses that result from nonconducting ablated tissue and anatomical obstructions. Often detailed mapping is not required for these tachycardias to be ablated, and the isthmuses are "expected" as a consequence of the previous ablation. 4 In contrast, other AT circuits may involve isthmuses that are not in prototypical locations and we denote these as "unexpected." Unexpected isthmuses are more difficult to map and successfully ablate.
TA B L E 3 Isthmus characteristics between Map 1 and Map 2
MAP 1 MAP 2
Nonconducting-Nonconducting
While many of the isthmuses identified in this study were "expected,"
RM activation threshold helped identify "unexpected isthmuses" bordered by idiopathic nonconductive tissue not obviously related to prior ablation delivery. These isthmuses formed the critical isthmus of an AT in some cases, hence would have been a likely cause for arrhythmia recurrence without identification using RM in this manner.
Substrate-guided AF ablation studies have shown benefit in targeting low-voltage areas, presumed atrial fibrosis. [27] [28] [29] The voltage threshold used to define these low-voltage areas for ablation in these studies was arbitrary, and high recurrence rate at 1 year may reflect this arbitrary classification. Accepting that low-voltage atrial fibrosis in the preablated atrium may be different to postablation myocardium, our approach to identifying nonconducting tissue may offer a more individualized approach to identify this low-voltage substrate for AF ablation as well, and requires further study. While we hypothesize that a strategy based on systematic ablation of all isthmuses might reduce future atrial arrhythmia burden, it also increases tissue destruction.
However, in an era where LA voltage substrate ablation for persistent AF is under evaluation, a method that involves isthmus ablation is potentially less destructive than voltage alone, and requires further study.
LIMITATIONS
This was a retrospective study with a small sample size, though the concept is hypothesis generating for future prospective studies. The absolute value of the activation threshold determined by this method of identifying conducting tissue is dependent on the recording technique and noise threshold of the recording system, which will influence the resolution and quality of the electrograms that are used for the Ripple Maps. Thus, these areas of scar are not necessarily dense fibrosis, but regions where some of the signals were low amplitude such that a propagating wave through the region could not be identified.
CONCLUSIONS
This study demonstrates that there is general concordance in the distribution of conducting isthmuses and nonconducting regions in the ablated left atrium, as depicted with RM and active tissue thresholding, despite altering the activation vector or atrial rate. This method requires further study, but potentially allows the isthmuses for tachycardias to be identified from maps of different atrial rhythms.
Using RM active tissue thresholding to define all isthmuses when mapping an AT might allow further proarrhythmic substrate to be targeted.
